购物车
- 全部删除
- 您的购物车当前为空
Bromfenac sodium hydrate (Bromfenac monosodium salt sesquihydrate) 是一种可口服的 COX 抑制剂,抑制 COX-1和COX-2的IC50值分别为 5.56 和 7.45 nM。它是一种溴化非甾体类抗炎药,有用于白内障的术后炎症和疼痛以及假晶状体囊状黄斑水肿的研究。
Bromfenac sodium hydrate (Bromfenac monosodium salt sesquihydrate) 是一种可口服的 COX 抑制剂,抑制 COX-1和COX-2的IC50值分别为 5.56 和 7.45 nM。它是一种溴化非甾体类抗炎药,有用于白内障的术后炎症和疼痛以及假晶状体囊状黄斑水肿的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 178 | 现货 | |
25 mg | ¥ 278 | 现货 | |
50 mg | ¥ 369 | 现货 | |
100 mg | ¥ 447 | 现货 | |
500 mg | ¥ 1,120 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 119 | 现货 |
产品描述 | Bromfenac sodium hydrate (Bromfenac monosodium salt sesquihydrate) is the sodium salt form of bromfenac, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory activities. Upon ophthalmic administration, bromfenac binds to and inhibits the activity of cyclooxygenase II (COX II), an enzyme which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins (PG). By inhibiting PG formation, bromfenac is able to inhibit PG-induced inflammation, thereby preventing vasodilation, leukocytosis, disruption of the blood-aqueous humor barrier, an increase in vascular permeability and an increase in intraocular pressure (IOP). |
靶点活性 | COX-1:5.56 nM (IC50), COX-2:7.45 nM (IC50) |
别名 | Bromfenac sodium sesquihydrate, Bromfenac monosodium salt sesquihydrate |
分子量 | 383.17 |
分子式 | C15H12BrNO3·3/2H2O·Na |
CAS No. | 120638-55-3 |
Smiles | O.[Na+].Nc1c(CC([O-])=O)cccc1C(=O)c1ccc(Br)cc1 |
密度 | 1.565 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 12.5 mg/mL (32.62 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容